MedPath

Effectiveness of psychotherapy in the treatment of social phobia

Not Applicable
Conditions
social phobia.
Fear of scrutiny by other people leading to avoidance of social situations. More pervasive social phobias are usually associated with low self-esteem and fear of criticism. They may present as a complaint of blushing, hand tremor, nausea, or urgency of mi
?F40.1
Registration Number
IRCT2012103011328N1
Lead Sponsor
Tehran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
45
Inclusion Criteria

having social phobia criteria based on the SCID; SPIN score greater than or equal to 24; age between 18 to 50 years;
Exclusion criteria: psychotic disorders; obsessive - compulsive disorder; bipolar disorder; organic brain injury; addiction to drugs and alcohol; impaired impulse control; Cluster A and B personality disorders; disorder on Axis III; history of attempt and suicidal ideation; history of violent behavior; psychotherapy for social phobia over the last 6 months; If there are any other psychotic disorders (except stated in the first clause), primary complaint is not symptoms of social phobia.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of symptoms of social phobia- clinician rating. Timepoint: The psychotherapy Group at weeks 1, 8, 15, 23 and the medication group at weeks 1, 4, 8, 12, and the waiting list group at weeks1, 4, 6, 8. Method of measurement: clinical global impression - severity.;Severity of symptoms of social phobia- Patient rating. Timepoint: The psychotherapy Group at weeks 1, 8, 15, 23 and the medication group at weeks 1, 4, 8, 12, and the waiting list group at weeks1, 4, 6, 8. Method of measurement: social phobia inventory (SPIN).;Improvement rate in symptoms of social phobia. Timepoint: The psychotherapy group at weeks 8, 15, 23 and the medication group at weeks 4, 8, 12, and the waiting list group at weeks 4, 6, 8. Method of measurement: Using the Clinical Global Impression of Improvement scale, CGI-I.
Secondary Outcome Measures
NameTimeMethod
Global Function. Timepoint: the Psychotherapy group at weeks 1, 23 and the medication group at weeks 1, 12 and the waiting list group at weeks1, 8. Method of measurement: Using the GAF Scale to assess the global functioning.
© Copyright 2025. All Rights Reserved by MedPath